NUV-1156

N/A

Report date: 2023/05/18 09:48:32

NME

Base Information

Drug NameNUV-1156

Drug Alias NameNUV-1156

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitorsAndrogen Receptor antagonists

TargetsPoly (ADP-Ribose) polymeraseAndrogen Receptor

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNuvation Bio Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A